𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension

✍ Scribed by R. Sadushi-Koliçi; W. Perthold; F. M. Fruhwald; I. M. Lang

Book ID
108713661
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
166 KB
Volume
38
Category
Article
ISSN
0014-2972

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in pulmonary hemodynamics du
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
✍ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope

Pulmonary edema complicating prostacycli
Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: A case of pulmonary capillary hemangiomatosis
✍ Manish K. Gugnani; Chris Pierson; Richard Vanderheide; Reda E. Girgis 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Continuous intravenous infusion of prostacyclin is an effective treatment for primary pulmonary hypertension (PPH), and has recently been shown to be of benefit in PH associated with scleroderma (SSc). Pulmonary capillary hemangiomatosis (PCH) is a rare cause of PPH. Prostacyclin therapy has been co